ROIV
Roivant Sciences Ltd.
🇺🇸 NYSE/NASDAQ
👑 Overview
📈 Performance
💵 Cost
🍃 Esg
🤓 Advanced
👨👩👧👦 Community
📈
+ 3.85%
Annual Growth
4 years average annual growth
🌏
3
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Roivant Sciences Ltd. is a biopharmaceutical company focused on improving the lives of patients by accelerating the development and commercialization of medicines that matter. The Company’s pipeline includes product candidates across various therapeutic areas, including immunology, oncology, hematology, and dermatology. Its pipeline includes IMVT-1402 and batoclimab, fully human monoclonal antibodies targeting FcRn in development across several IgG-mediated autoimmune indications; brepocitinib, a small molecule inhibitor of TYK2 and JAK1 in development for the treatment of dermatomyositis and non-infectious uveitis; mosliciguat, an inhaled soluble sGC activator in development for pulmonary hypertension associated with interstitial lung disease, in addition to other clinical-stage molecules; and namilumab, is a fully human monoclonal antibody targeting granulocyte-macrophage colony stimulating factor, an inflammatory cytokine involved in inflammatory disorders such as sarcoidosis.
📈 Performance
Price History*
+15.22%
1M
1Y
All Time
Graph
Table
* US price history does not take into account stock splits
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$11.49
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in ROIV
3
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
45 weeks
💵 Average investment amount
$451
⏰ Last time a customer invested in ROIV
9 days
ROIV investor breakdown
💵 Income of investors
More than 200k
33%
150k - 200k
33%
100k - 150k
50k - 100k
Less than 50k
33%
👶 Age of investors
18 - 25
26 - 34
33%
35 - 90
67%
🙋 Legal gender of investors
Female
Male
100%
Pearlers who invest in ROIV also invest in...
🙌 Performance (5Yr p.a)
16.04%
📊 Share price
$45.28 USD
📈 HIGH PRICE GROWTH
🙌 Performance (5Yr p.a)
8.75%
📊 Share price
$24.42 USD
📈 HIGH PRICE GROWTH
Want more shares? Try these...
🙌 Performance (5Yr p.a)
8.70%
📊 Share price
$280.08 USD
📈 HIGH PRICE GROWTH